Biotech Values

[DewDiligence]

Re: PFE + WYE

Agreed, it's just an assumption based on nothing more than the general observation that the acquirer's PPS usually declines.

The acquirer’s share price usually declines initially, but there is no basis for thinking that it will continue to decline day after day, which is what you asserted in #msg-35080442.

On Friday I was listening to an analyst on CNBC describe the deal as (and I'm paraphrasing from memory here) "two train wrecks merging into one train wreck."

The CNBC analyst is clueless. Acquiring WYE at the price being paid is absolutely the best move PFE could have made.